Edges in Network
Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | WT1 |
Upstream (Parents) |
---|
(<<) EHF → WT1 |
(<<) MAF → WT1 |
(<<) JUND → WT1 |
(<<) PCGF2 → WT1 |
(<<) HES1 → WT1 |
(<<) GLIS2 → WT1 |
(<<) IRX5 → WT1 |
(<<) CREM → WT1 |
(<<) GLI3 → WT1 |
(<<) FOXO3 → WT1 |
(<<) MSRB2 → WT1 |
(<<) ZHX1 → WT1 |
(<<) CREB1 → WT1 |
(<<) EPAS1 → WT1 |
(<<) HDX → WT1 |
(<<) HMGB1 → WT1 |
(<<) CEBPD → WT1 |
(<<) CBFA2T2 → WT1 |
(<<) STAT3 → WT1 |
(<<) NFATC3 → WT1 |
(<<) JUN → WT1 |
(<<) SUPT4H1 → WT1 |
(<<) SUPT6H → WT1 |
(<<) NR3C1 → WT1 |
(<<) STAT2 → WT1 |
Downstream (Children) |
---|
WT1 → OVOL1 (>>) |
WT1 → SALL2 (>>) |
WT1 → C1orf85 (>>) |